BioSpace News Archive

Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and slow neurodegeneration, today announced the presentation of preclinical data on two small molecule positive modulators of the HGF/MET signaling pathway, ATH-1018 and ATH-1019, at the 2022 Peripheral Nerve Society (PNS) Annual Meeting.

Centessa Pharmaceuticals plc reported financial results for the first quarter ended March 31, 2022 and provided business updates.

AIM ImmunoTech Inc., an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, immune disorders, and viral diseases, including COVID-19, the disease caused by the SARS-CoV-2 virus, reported its financial results for the first quarter 2022 and provided a business update.

Kala Pharmaceuticals, Inc. reported financial results for the first quarter ended March 31, 2022 and provided a corporate update.

Galera Therapeutics, Inc. (Nasdaq: GRTX), a clinical-stage biopharmaceutical company focused on developing and commercializing a pipeline of novel, proprietary therapeutics that have the potential to transform radiotherapy in cancer, today announced financial results for the first quarter ended March 31, 2022 and provided recent corporate updates.

Altimmune, Inc., a clinical-stage biopharmaceutical company, announced that members of the Company’s management team will participate at the following investor conferences in May 2022:

Alaunos Therapeutics, Inc. (“Alaunos” or the “Company”) (Nasdaq: TCRT), a clinical-stage oncology-focused cell therapy company today announced financial results for the first quarter ended March 31, 2022.

Spectral Medical Inc. today announced the appointment of Samuel Amory as President of Dialco.

Biomea Fusion, Inc. (Nasdaq: BMEA), a clinical-stage biopharmaceutical company dedicated to discovering and developing novel covalent small molecules to treat and improve the lives of patients with genetically defined cancers and metabolic diseases, reported first quarter 2022 financial results and business highlights.

Gracell Biotechnologies Reports First Quarter 2022 Unaudited Financial Results and Provides Corporate Update.